<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The t(14;18) chromosomal translocation is the most common cytogenetic abnormality in non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL), occurring in 70-90% of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (FL) and 30-50% of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Previous t(14;18)-NHL studies have not evaluated risk factors for NHL defined by both t(14;18) status and histology </plain></SENT>
<SENT sid="2" pm="."><plain>In this population-based case-control study, t(14;18) status was determined in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> cases using fluorescence in situ hybridization on paraffin-embedded <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sections </plain></SENT>
<SENT sid="3" pm="."><plain>Polytomous logistic regression was used to evaluate the association between a wide variety of exposures and t(14;18)-positive (N=109) and -negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (N=125) and FL (N=318), adjusting for sex, age, race, and study center </plain></SENT>
<SENT sid="4" pm="."><plain>Taller height, more lifetime surgeries, and PCB180 exposure were associated with t(14;18)-positivity </plain></SENT>
<SENT sid="5" pm="."><plain>Taller individuals (third tertile vs. first tertile) had elevated risks of t(14;18)-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (odds ratio [OR] = 1.8, 95% confidence interval [CI] 1.1-3.0) and FL (OR=1.4, 95%CI 1.0-1.9) but not t(14;18)-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Similar patterns were seen for individuals with more lifetime surgeries (13+ vs. 0-12 surgeries; t(14;18)-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> OR=1.4, 95%CI 0.7-2.7; FL OR=1.6, 95%CI 1.1-2.5) and individuals exposed to PCB180 greater than 20.8 ng/g (t(14;18)-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> OR=1.3, 95%CI 0.6-2.9; FL OR=1.7, 95%CI 1.0-2.8) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, termite treatment and high <z:chebi fb="0" ids="39068">alpha-chlordane</z:chebi> levels were associated with t(14;18)-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> only, suggesting that these exposures do not act through t(14;18) </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings suggest that putative associations between NHL and height, surgeries, and PCB180 may be t(14;18)-mediated and provide support for case-subtyping based on molecular and histologic subtypes </plain></SENT>
<SENT sid="9" pm="."><plain>Future efforts should focus on pooling data to confirm and extend previous research on risk factors for t(14;18)-NHL subtypes </plain></SENT>
</text></document>